170 related articles for article (PubMed ID: 14764453)
1. LR11, an LDL receptor gene family member, is a novel regulator of smooth muscle cell migration.
Zhu Y; Bujo H; Yamazaki H; Ohwaki K; Jiang M; Hirayama S; Kanaki T; Shibasaki M; Takahashi K; Schneider WJ; Saito Y
Circ Res; 2004 Apr; 94(6):752-8. PubMed ID: 14764453
[TBL] [Abstract][Full Text] [Related]
2. A secreted soluble form of LR11, specifically expressed in intimal smooth muscle cells, accelerates formation of lipid-laden macrophages.
Ohwaki K; Bujo H; Jiang M; Yamazaki H; Schneider WJ; Saito Y
Arterioscler Thromb Vasc Biol; 2007 May; 27(5):1050-6. PubMed ID: 17332490
[TBL] [Abstract][Full Text] [Related]
3. Enhanced expression of the LDL receptor family member LR11 increases migration of smooth muscle cells in vitro.
Zhu Y; Bujo H; Yamazaki H; Hirayama S; Kanaki T; Takahashi K; Shibasaki M; Schneider WJ; Saito Y
Circulation; 2002 Apr; 105(15):1830-6. PubMed ID: 11956127
[TBL] [Abstract][Full Text] [Related]
4. Pitavastatin attenuates the PDGF-induced LR11/uPA receptor-mediated migration of smooth muscle cells.
Jiang M; Bujo H; Zhu Y; Yamazaki H; Hirayama S; Kanaki T; Shibasaki M; Takahashi K; Schneider WJ; Saito Y
Biochem Biophys Res Commun; 2006 Oct; 348(4):1367-77. PubMed ID: 16919601
[TBL] [Abstract][Full Text] [Related]
5. Urokinase-receptor-mediated phenotypic changes in vascular smooth muscle cells require the involvement of membrane rafts.
Kiyan J; Smith G; Haller H; Dumler I
Biochem J; 2009 Oct; 423(3):343-51. PubMed ID: 19691446
[TBL] [Abstract][Full Text] [Related]
6. LRP1B attenuates the migration of smooth muscle cells by reducing membrane localization of urokinase and PDGF receptors.
Tanaga K; Bujo H; Zhu Y; Kanaki T; Hirayama S; Takahashi K; Inoue M; Mikami K; Schneider WJ; Saito Y
Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1422-8. PubMed ID: 15166012
[TBL] [Abstract][Full Text] [Related]
7. Modulation of smooth muscle cell migration by members of the low-density lipoprotein receptor family.
Bujo H; Saito Y
Arterioscler Thromb Vasc Biol; 2006 Jun; 26(6):1246-52. PubMed ID: 16574889
[TBL] [Abstract][Full Text] [Related]
8. Ang II-stimulated migration of vascular smooth muscle cells is dependent on LR11 in mice.
Jiang M; Bujo H; Ohwaki K; Unoki H; Yamazaki H; Kanaki T; Shibasaki M; Azuma K; Harigaya K; Schneider WJ; Saito Y
J Clin Invest; 2008 Aug; 118(8):2733-46. PubMed ID: 18618022
[TBL] [Abstract][Full Text] [Related]
9. Urokinase plasminogen activator receptor promotes macrophage infiltration into the vascular wall of ApoE deficient mice.
Gu JM; Johns A; Morser J; Dole WP; Greaves DR; Deng GG
J Cell Physiol; 2005 Jul; 204(1):73-82. PubMed ID: 15573379
[TBL] [Abstract][Full Text] [Related]
10. Blockade of angio-associated migratory cell protein inhibits smooth muscle cell migration and neointima formation in accelerated atherosclerosis.
Vogt F; Zernecke A; Beckner M; Krott N; Bosserhoff AK; Hoffmann R; Zandvoort MA; Jahnke T; Kelm M; Weber C; Blindt R
J Am Coll Cardiol; 2008 Jul; 52(4):302-11. PubMed ID: 18634987
[TBL] [Abstract][Full Text] [Related]
11. EGF-stimulated migration in ovarian cancer cells is associated with decreased internalization, increased surface expression, and increased shedding of the urokinase plasminogen activator receptor.
Henic E; Sixt M; Hansson S; Høyer-Hansen G; Casslén B
Gynecol Oncol; 2006 Apr; 101(1):28-39. PubMed ID: 16263158
[TBL] [Abstract][Full Text] [Related]
12. Ablation of MEK kinase 1 suppresses intimal hyperplasia by impairing smooth muscle cell migration and urokinase plasminogen activator expression in a mouse blood-flow cessation model.
Li Y; Minamino T; Tsukamoto O; Yujiri T; Shintani Y; Okada K; Nagamachi Y; Fujita M; Hirata A; Sanada S; Asanuma H; Takashima S; Hori M; Johnson GL; Kitakaze M
Circulation; 2005 Apr; 111(13):1672-8. PubMed ID: 15795331
[TBL] [Abstract][Full Text] [Related]
13. Biomechanically induced gene iex-1 inhibits vascular smooth muscle cell proliferation and neointima formation.
Schulze PC; de Keulenaer GW; Kassik KA; Takahashi T; Chen Z; Simon DI; Lee RT
Circ Res; 2003 Dec; 93(12):1210-7. PubMed ID: 14592999
[TBL] [Abstract][Full Text] [Related]
14. Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice.
Bauer TW; Liu W; Fan F; Camp ER; Yang A; Somcio RJ; Bucana CD; Callahan J; Parry GC; Evans DB; Boyd DD; Mazar AP; Ellis LM
Cancer Res; 2005 Sep; 65(17):7775-81. PubMed ID: 16140945
[TBL] [Abstract][Full Text] [Related]
15. Mitogenic signaling of urokinase receptor-deficient kidney fibroblasts: actions of an alternative urokinase receptor and LDL receptor-related protein.
Zhang G; Cai X; López-Guisa JM; Collins SJ; Eddy AA
J Am Soc Nephrol; 2004 Aug; 15(8):2090-102. PubMed ID: 15284295
[TBL] [Abstract][Full Text] [Related]
16. LRP1B is a negative modulator of increased migration activity of intimal smooth muscle cells from rabbit aortic plaques.
Seki N; Bujo H; Jiang M; Tanaga K; Takahashi K; Yagui K; Hashimoto N; Schneider WJ; Saito Y
Biochem Biophys Res Commun; 2005 Jun; 331(4):964-70. PubMed ID: 15882972
[TBL] [Abstract][Full Text] [Related]
17. Reduced beta3-endonexin levels are associated with enhanced urokinase-type plasminogen activator receptor expression in ApoE-/- mice.
Besta F; Müller I; Lorenz M; Massberg S; Bültmann A; Cabeza N; Richter T; Kremmer E; Nothdurfter C; Brand K; Gawaz M
Thromb Res; 2004; 114(4):283-92. PubMed ID: 15381392
[TBL] [Abstract][Full Text] [Related]
18. Migrating vascular smooth muscle cells polarize cell surface urokinase receptors after injury in vitro.
Okada SS; Tomaszewski JE; Barnathan ES
Exp Cell Res; 1995 Mar; 217(1):180-7. PubMed ID: 7867716
[TBL] [Abstract][Full Text] [Related]
19. Expression of LR11, a mosaic LDL receptor family member, is markedly increased in atherosclerotic lesions.
Kanaki T; Bujo H; Hirayama S; Ishii I; Morisaki N; Schneider WJ; Saito Y
Arterioscler Thromb Vasc Biol; 1999 Nov; 19(11):2687-95. PubMed ID: 10559012
[TBL] [Abstract][Full Text] [Related]
20. CREG inhibits migration of human vascular smooth muscle cells by mediating IGF-II endocytosis.
Han Y; Cui J; Tao J; Guo L; Guo P; Sun M; Kang J; Zhang X; Yan C; Li S
Exp Cell Res; 2009 Nov; 315(19):3301-11. PubMed ID: 19769965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
